Search
for
Sort by
Research 541–570 of 1000+
- Androgen effects on the skin
- Development of polycystic ovary syndrome: involvement of genetic and environmental factors
- Evaluation of hyperandrogenemia and metabolic risk profile in women with postadolescent acne
- Clinical characteristics in Taiwanese women with polycystic ovary syndrome
- Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial
- Nanostructured lipid carriers loaded with an association of minoxidil and latanoprost for targeted topical therapy of alopecia
- A pilot study to explore postpartum body image and resumed menstruation
- Response to Park et al. on the Clinical Use of Hair Diameter Diversity in Androgenetic Alopecia
- COVID-19 and Sex Differences
- Lack of association between clinical and biochemical hyperandrogenism in patients with polycystic ovary syndrome
- A Fuzzy Logic-Based Computational Framework for Precision Triage in Androgenetic Alopecia: A Simulated Biomarker-Driven Approach
- Postmenopausal frontal fibrosing alopecia. Scarring alopecia in a pattern distribution
- Postmenopausal Frontal Fibrosing Alopecia
- No Evidence that 2D:4D is Related to the Number of CAG Repeats in the Androgen Receptor Gene
- Evidence of Increased 3‐Alpha‐Androstanediol Glucuronide in Female Pattern Alopecia: A Cross‐Sectional Observational Study Evaluating Ovarian, Adrenal, and Peripheral Androgens
- Methods for Treating Androgenic Alopecia by Restoration of Morphogenetic Field Connectivity in Hair Follicle Networks
- EVALUATION OF FETUIN-A LEVEL IN POLYCYSTIC OVARY SYNDROME AND ITS ASSOCIATION WITH ASPROSIN AND SOME BIOCHEMICAL PARAMETERS.
- Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
- Nanostructured Lipid Carriers Loaded with an Association of Minoxidil and Latanoprost for Targeted Topical Therapy of Alopecia
- Impact of subclinical hypothyroidism on endocrine features in patients with polycystic ovary syndrome
- Thiol/disulfide homeostasis in patients with telogen effluvium: is oxidative stress important in the pathogenesis of telogen effluvium?
- Aesthetically relevant symptoms of menopause transition: Impact and approach to management
- Perspective Chapter: Beyond BMI – Rethinking Obesity Assessment in Women’s Health
- Ex vivo detection of SARS CoV 2 spike protein in human hair follicles and potential link to telogen effluvium
- The investigation and management of hirsutism
- Serum AMH levels in the differential diagnosis of hyperandrogenemic conditions
- The Frequency of Various Phenotypes of Polycystic Ovarian Syndrome in Adolescents, Based on Rotterdam Criteria
- Serum Prostate Specific Antigen level in Women with Polycystic Ovary Syndrome
- Pathophysiology of Androgenetic Alopecia and Implications for Treatment: An Overview of Current Literature
- From male PCOS to male endocrine-metabolic syndrome: a gender-neutral hypothesis